INTERVIEWS

Dr. Eddie Fatakhov, MD, a board-certified internist from Atlanta discusses the efficiency and effectiveness of Far-UV Light and how it is able to kill the COVID-19 Coronavirus in one-tenth of a second, while not harming human skin or eyesight, and eliminating inefficient and ineffective continual hand washing and hand sanitizing.  It is a special lamp with a particular patented form of UV light known as “Excimer Wave Sterilray™” light, with a wavelength at 222 nm (nanometers), a form of Far-UV light that has a very short range in biological material but it can penetrate and kill viruses floating in the air, on surfaces, in liquids, etc., including COVID-19, disrupting its DNA structure and amino acids, killing it.   He hopes for FDA approval and funding for mass production of these Far-UV lights that can save millions of lives and end the COVID-19 Coronavirus Pandemic, as well as annihilate future epidemics in their infancy.

Indy car driver, Charlie Kimball, talks about managing his type 1 diabetes with a continuous glucose monitor (CGM) that has made it possible for him to know his blood sugar numbers in nearly real-time and make small but meaningful adjustments to his insulin dosing throughout the day. He also discusses his 12th race season working with Novo Nordisk’s Race with Insulin® program.

For Progressive Multiple Sclerosis Day 2020 patient Vickie Siculiano shares her journey living with primary progressive multiple sclerosis.

Todd Norwood, Director of Clinical Services discusses Physera, a telehealth company that offers consumers/patients virtual physical therapy with licensed physical therapists from the comfort and safety of their homes.

Dr. Tracy Frech, a rheumatologist from the University of Utah discusses her work with Corbus Pharmaceuticals to address systemic sclerosis (SSc) through a disease state education program with a new website geared towards physicians.  The program will provide resources to better equip them for treating their patients and understanding the need to address the totality of SSc, a rare, complex and debilitating disease.

Dr. Bruce Clark, CEO of Medicago, a biopharmaceutical company headquartered in Quebec City, and a leader in plant-based technology, discusses the announcement on March 12, 2020, that they had successfully produced a Virus-Like Particle (VLP) of the corona virus just 20 days after obtaining the SARS-CoV-2 (virus causing the COVID-19 disease) gene using plant-based technology.  Production of the VLP is the first step in developing a vaccine for COVID-19, which will now undergo preclinical testing for safety and efficacy. Once this is completed, Medicago expects to discuss with the appropriate Health Agencies to initiate human trials of the vaccine by summer (July/August) 2020.

Rebecca Kasen, advocacy director at Community Access Unlimited (CAU) in New Jersey discusses what the month of March as Developmental Disability Awareness Month means to them and the many programs available to assist people.  CAU assists with housing, life skills, employment, money management, socialization, civic activities, and so much more.

Dr. Jacqueline Jones, MD, one of America’s Top Doctors™, discusses concerns about coronavirus from the parent/child perspective and her latest book “Medical Parenting: How to Navigate Health, Wellness & The Medical System with Your Child“. 

Dr. Payam Shakouri, a nephrologist, discusses uncontrolled gout and its connection to chronic kidney disease (CKD).  Approximately 1 in 4 adults with CKD has gout. It’s 10x more likely for a person with moderate-to-severe CKD to have gout than someone who does not.

Adam Cogar, a kidney transplant recipient, talks about his 15-year journey to a diagnosis of uncontrolled gout.  He discusses how the pain had impacted his daily life and how different his life is now that he has a clear diagnosis, treatment plan in place, and can manage his condition.  The prevalence of gout is more than ten-fold greater among patients who have undergone a kidney transplant than the general population.